GLP-1 Weight Loss and PCOS: A Promising Treatment Approach
Weight Loss
5
Min Read

GLP-1 Weight Loss and PCOS: A Promising Treatment Approach

At a glance

For a comprehensive guide to medical weight loss for women, see our complete guide.

GLP-1 Weight Loss and PCOS: A Promising Treatment Approach

For a comprehensive guide to medical weight loss for women, see our complete guide.

Medically reviewed by Dr. Kevin Chua, Medical Director

Disclaimer: This article provides general medical information and is not a substitute for professional medical advice. Always consult a licensed doctor before starting any treatment.


Introduction

Polycystic ovary syndrome (PCOS) is frustrating to live with partly because of a cruel metabolic irony: it makes weight loss significantly harder at the same time that losing weight is one of the most effective things you can do to improve your symptoms.

GLP-1 medications break this cycle. They address the insulin resistance that underpins most PCOS-related weight gain, and they do so directly — not as a side effect, but as part of their core mechanism. This guide covers how GLP-1 treatment works specifically in women with PCOS, what improvements to expect, and what to discuss with your doctor.


What PCOS Does to Weight Management

PCOS is not just a fertility condition. It's a metabolic disorder, and weight is deeply entangled in its symptom picture.

Insulin Resistance — The Central Problem

Up to 70–80% of women with PCOS have some degree of insulin resistance, even those of normal weight[^1]. Insulin resistance means your body's cells don't respond efficiently to insulin, so the pancreas produces more of it. This elevated insulin:

  • Stimulates the ovaries to produce more androgens (testosterone, DHEA-S)
  • Promotes fat storage, particularly in the abdomen
  • Suppresses ovulation, disrupting the menstrual cycle
  • Drives increased appetite and food cravings (particularly for carbohydrates)

The result: a hormonal environment that actively works against weight loss.

Why Standard Dieting Is Harder with PCOS

Women with PCOS typically require a more significant caloric deficit to achieve the same weight loss as women without PCOS — a finding supported by multiple studies. The elevated insulin and androgen environment creates greater appetite drive, higher fat storage efficiency, and more difficulty accessing stored fat for energy.

This is not a failure of character. It is biology.


How GLP-1 Medications Target PCOS Specifically

GLP-1 receptor agonists were originally developed for type 2 diabetes — a condition that shares core mechanisms with PCOS (insulin resistance, impaired glucose metabolism). Their benefits for PCOS flow directly from these mechanisms.

1. Insulin Sensitisation

GLP-1 medications improve insulin sensitivity. This reduces the elevated insulin that drives androgen overproduction, creating a cascade of improvements:

  • Less androgen production → reduced acne, less excess facial/body hair
  • More regular ovulation → improved menstrual regularity
  • Better glucose tolerance → reduced blood sugar spikes and crashes

2. Weight Loss

Even a 5–10% reduction in body weight significantly improves PCOS symptoms. At 10–20% weight loss (achievable with GLP-1 medications), the improvements can be dramatic. Women with PCOS who lose meaningful weight often see:

  • Restoration of regular menstrual cycles
  • Improved fertility outcomes
  • Reduced androgen levels on blood tests
  • Better psychological wellbeing

3. Direct Appetite Regulation

The appetite suppression from GLP-1 medications addresses the biologically elevated hunger drive that makes PCOS so difficult to manage through willpower alone. Many women with PCOS describe feeling "out of control" around food — particularly sweet or starchy foods. GLP-1 treatment reduces this urge significantly for most users.


What Clinical Evidence Shows

Direct PCOS trials with GLP-1 medications are fewer than in the broader obesity population, but existing evidence is encouraging:

  • Multiple small-to-medium trials show semaglutide and liraglutide produce meaningful weight loss in women with PCOS
  • Studies demonstrate improvements in testosterone levels, menstrual regularity, and inflammatory markers alongside weight loss[^2]
  • Combination approaches (GLP-1 + metformin, or GLP-1 + OCP) show additive benefits for different aspects of PCOS
  • The SURMOUNT-1 trial (tirzepatide) showed average 20.9% weight loss — data in PCOS specifically are pending but expected to follow the pattern[^3]

GLP-1 Medications vs Metformin for PCOS

Metformin has been used off-label for PCOS for decades. How do GLP-1 medications compare?

Metformin GLP-1 (e.g., semaglutide)
Weight loss Modest (2–3 kg average) Significant (10–20%+ body weight)
Insulin sensitivity Improves Improves
Androgen levels Modest reduction Significant reduction (via weight loss)
Menstrual regularity Some improvement Significant improvement
Cost Very affordable (~S$15–30/month) Higher (S$200–500/month)
Route Oral, daily Injection or oral, weekly/daily
GI side effects Common initially Common initially

These are not mutually exclusive. Some doctors combine metformin and GLP-1 medications for additive benefits.


Fertility Considerations

An important caution: if you have PCOS and have not been regularly ovulating, starting GLP-1 treatment (and losing weight) may restore ovulation. If you are not trying to conceive, this means you need reliable contraception — do not assume irregular periods mean you cannot get pregnant.

If you are trying to conceive: - Discuss with your doctor before starting GLP-1 treatment — some fertility specialists want weight loss established before fertility treatment begins - GLP-1 medications must be stopped before trying to conceive (at least 2 months for semaglutide) - Weight loss of 10–15% before fertility treatment significantly improves IVF outcomes in women with PCOS


Cost in Singapore (SGD)

GLP-1 receptor agonist medications for weight management in Singapore typically cost SGD $200–500 per month depending on the specific medication and dosage. zoey™ offers structured weight management plans with ongoing doctor oversight and support.

Prices are approximate and may vary. Updated April 2026.


FAQ

1. Does PCOS affect how well GLP-1 medications work?

Women with PCOS generally respond well to GLP-1 medications — the insulin-sensitising effect is particularly beneficial. Some evidence suggests women with PCOS may achieve comparable or better results than the general overweight population.

2. Will GLP-1 medication fix my irregular periods?

Not directly, and not guaranteed. But weight loss of 5–10% has been shown to restore regular cycles in many women with PCOS. GLP-1-driven weight loss of 10–15%+ produces more substantial hormonal improvements.

3. Do I need a PCOS diagnosis to start GLP-1 treatment for weight loss?

No. Eligibility is based on BMI and comorbidities — PCOS qualifies as a comorbidity that lowers the BMI threshold to 25. But you don't need a PCOS diagnosis to access weight loss treatment.

4. Can I take GLP-1 medication and the OCP together?

Yes, with appropriate discussion about the oral contraceptive absorption interaction. See our GLP-1 and contraception guide for detail.

5. Is GLP-1 treatment available for lean women with PCOS (BMI under 25)?

Most GLP-1 weight loss prescriptions require a BMI of 25+ (with comorbidities) or 27.5+. For lean women with PCOS, metformin and OCPs remain first-line. Discuss with your doctor — eligibility criteria are assessed individually.


References

[^1]: Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev. 1997;18(6):774-800. PMID: 9408743 [^2]: Corcoran C, Jacobs TF. Metformin. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023. [^3]: Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide once weekly for the treatment of obesity. N Engl J Med. 2022;387(3):205-216. PMID: 35658024


→ Return to pillar: Complete Guide to Medical Weight Loss for Women

This article is for informational purposes only and does not constitute medical advice. Always consult a licensed doctor before starting any treatment.

Find out what your BMI indicates

Your BMI indicates that you may be
Slider
BMI provides an estimate of weight classification. For a thorough analysis of your weight and medical options, arrange a teleconsult with a Zoey doctor.

*Medical treatment may not be appropriate for you even if you have a high BMI
Your estimated weight loss in 1 year*
-
00
kg
-9%
90
kg
78
kg
99
81
63
Transparent weight loss progress graph illustration showing body weight reduction over time on a treatment programme
*In a 56-week trial with 3,731 non-diabetic overweight (BMI ≥27) or obese (BMI ≥30) participants, those who finished (1,812 patients) lost an average of 9.2% body weight with Saxenda, alongside diet and exercise.
medically reviewed by
Dr. Kevin Chua, Medical Director
Written by our
last updated
April 20, 2026
DISCLAIMER

Articles featured on Zoey are for informational purposes only and should not be constituted as medical advice, diagnosis or treatment. If you have any medical questions or concerns, please talk to your healthcare provider. If you're looking for a healthcare provider, click here.

Arrow square up-right icon representing external links on the Zoey SG website
References
No items found.